San Diego, California - April 2-6, 2018
SpiroChem is taking part in the 13th Annual Drug Discovery Chemistry Conference organised by the Cambridge Healthtech Institute from April 2-6, 2018 in San Diego, California. The event, mainly aimed for medicinal chemists working in pharma and biotech, is particularly in line with the scope of SpiroChem’s expertise.
Dr. Thomas Fessard, CEO of SpiroChem, who will be accompanied by Dr. Kristina Goncharenko; will be more than pleased to discuss SpiroChem’s innovative approach in the design and synthesis of novel building blocks, which has paved the way for drug discovery and will continue to inspire innovations in the field of medicinal chemistry.
Contact: Dr. Thomas Fessard
E-mail: thomas.fessard@spirochem.com
